Star Cement (540575) Q4 21/22 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 21/22 earnings summary
19 Oct, 2026Executive summary
FY22 consolidated revenue from operations reached ₹2,221.82 crore; PAT was ₹246.77 crore, with stronger demand and infrastructure activity lifting volumes late in the year.
Cement sales volume rose to 3.4 MMT from 2.64 MMT; the North-East market remained the core region, with 25.45 lakh tonnes sold there.
Financial strength remained solid, with net debt-free status highlighted and a planned expansion programme spanning clinker, grinding and waste-heat recovery capacity.
Financial highlights
Consolidated revenue from operations was ₹2,221.82 crore vs ₹1,719.93 crore in FY21; total income was ₹2,255.19 crore vs ₹1,748.15 crore.
Consolidated EBITDA before exceptional items was ₹378.62 crore vs ₹360.82 crore; PBT was ₹243.65 crore vs ₹199.26 crore.
Consolidated PAT was ₹246.77 crore vs ₹187.13 crore; EPS rose to ₹6.04 from ₹4.54.
Cement production increased to 34.06 lakh tonnes from 26.36 lakh tonnes; clinker production reached 21.75 lakh tonnes vs 19.11 lakh tonnes.
Outlook and guidance
FY23 cement sales volume target: 4 MMT, compared with FY22 sales of 3.4 MMT.
FY23 capex plan was ~₹300 crore; a 12 MW WHRB plant at Meghalaya was expected to begin operations by September 2022.
Expansion plans included a 3 MTPA clinker unit in Meghalaya and two 2 MTPA grinding units in Assam; capex of ₹2,200–2,500 crore was planned over 24 months.
Long-term capacity ambition: 15 MMT by 2026.
Latest events from Star Cement
- Record profits and sharp debt reduction set the stage for capacity-led growth.540575
Q4 17/18 - Profit rose despite a weak market, while regional sales and capacity expansion advanced.540575
Q4 16/17 - Revenue and cement volumes grew, but subsidy expiry cut earnings as expansion plans advanced.540575
Q4 18/19 - Volume growth and low gearing offset by weaker profits and uncertain FY21 demand.540575
Q4 19/20 - FY21 resilience, a 20.98% EBITDA margin and 2-MTPA Siliguri expansion.540575
Q4 20/21 - Higher volumes lifted FY23 results as major capacity expansion advanced.540575
Q4 22/23 - Q1 FY27 revenue rose but margins fell; expansion and H2 recovery expected as costs ease.540575
Q1 26/27 - Strong Q3 growth, interim dividend, and promoter reclassification highlight performance.540575
Q3 25/26 - Record Q4 sales, EBITDA, and PAT with strong growth, incentives, and capacity expansion.540575
Q4 24/25